Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fuji
Deloitte
US Army
Baxter
Cerilliant
Argus Health
US Department of Justice
Fish and Richardson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Wyeth Pharms Pfizer Company Profile

« Back to Dashboard

What is the competitive landscape for WYETH PHARMS PFIZER, and when can generic versions of WYETH PHARMS PFIZER drugs launch?

WYETH PHARMS PFIZER has one approved drug.

There are four US patents protecting WYETH PHARMS PFIZER drugs.

There are sixty-two patent family members on WYETH PHARMS PFIZER drugs in forty countries and ten supplementary protection certificates in nine countries.

Summary for Wyeth Pharms Pfizer
International Patents:62
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Wyeth Pharms Pfizer

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes 7,683,051 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes 5,998,402 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes 6,479,535 ➤ Try a Free Trial Y ➤ Try a Free Trial
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes 8,815,934 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Wyeth Pharms Pfizer

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,835,729 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Try a Free Trial
6,232,307 Tissue selective compounds in the treatment of ovarian cancer ➤ Try a Free Trial
6,127,404 Tissue selective compounds in the treatment of endometrial proliferation ➤ Try a Free Trial
6,787,538 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Wyeth Pharms Pfizer Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
608 Luxembourg ➤ Try a Free Trial 91608, EXPIRES: 20220415
0802183/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: BAZEDOXIFEN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58732 12.01.2010
2009 00035 Denmark ➤ Try a Free Trial
4 Finland ➤ Try a Free Trial
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Queensland Health
Moodys
Boehringer Ingelheim
UBS
Daiichi Sankyo
Julphar
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.